Sloots Kathryn L, Vinten-Johansen Jakob, Dobson Geoffrey P
Department of Physiology and Pharmacology, Molecular Science Building, James Cook University, Townsville, Queensland, Australia.
J Thorac Cardiovasc Surg. 2007 May;133(5):1171-8. doi: 10.1016/j.jtcvs.2006.12.058.
Continuous infusion of warm to normothermic cardioplegia may limit the surgeon's visual field, increase coronary vascular resistance, and lead to potassium-exacerbated ischemia-reperfusion damage. Our aim was to examine the versatility of a new normokalemic, nondepolarizing adenosine-lidocaine cardioplegia during continuous or intermittent infusion at 33 degrees C and compare it with lidocaine cardioplegia.
Isolated, perfused rat hearts (n = 6 each group) were arrested at 33 degrees C for 40 or 60 minutes with 200 microm of adenosine and 500 microm of lidocaine in Krebs-Henseleit buffer (10 mmol/L glucose, pH 7.6-7.7 at 37 degrees C) or 500 microm of lidocaine in Krebs-Henseleit buffer for 60 minutes delivered at 60 mm Hg.
Times to arrest were 7 to 10 seconds for the adenosine-lidocaine groups and 102 seconds for the lidocaine group (P < .05). Total cardioplegia volumes for intermittent (2 minutes every 18 minutes) and continuous deliveries were 122 to 159 mL and 699 to 922 mL for the 40- and 60-minute adenosine-lidocaine arrest protocols, respectively, and 136 mL for the 60-minute intermittent lidocaine group. In the last 2 minutes of the 40- and 60-minute arrest protocols, the coronary vascular resistance was not significantly different for the hearts arrested with adenosine and lidocaine (0.27-0.32 megadyne/sec/cm(-5)). Significantly higher coronary vascular resistance was found in the lidocaine cardioplegia group (0.38 megadyne/sec/cm(-5)). No significant differences were found between the continuous or intermittent adenosine-lidocaine delivery protocols. Hearts arrested with adenosine and lidocaine recovered 88% to 89% of aortic flow and 109% of coronary flow at 60 minutes of reperfusion after 40-minute arrest, and 77% to 86% of aortic flow and 98% to 109% of coronary flow at 60 minutes of reperfusion after 60-minute arrest. Lidocaine cardioplegia led to significantly lower aortic and coronary flows after 60-minute arrest compared with the intermittent adenosine-lidocaine group.
We conclude that adenosine-lidocaine cardioplegia can be delivered intermittently or continuously with similar functional recoveries after a 40- or 60-minute arrest at 33 degrees C. Hearts receiving lidocaine cardioplegia took a significantly longer time to arrest, showed higher coronary vascular resistance, and achieved lower functional recovery than the 60-minute adenosine-lidocaine cardioplegia groups. Intermittent or continuous delivery of adenosine-lidocaine cardioplegia may offer an alternative to current surgical hyperkalemic cardioplegia at warm to normothermic temperatures.
持续输注温热至常温的心脏停搏液可能会限制外科医生的视野,增加冠状动脉血管阻力,并导致钾加重的缺血-再灌注损伤。我们的目的是研究一种新型的正常血钾、非去极化的腺苷-利多卡因心脏停搏液在33℃持续或间断输注时的通用性,并将其与利多卡因心脏停搏液进行比较。
将离体灌注大鼠心脏(每组n = 6)在33℃下用含200微摩尔腺苷和500微摩尔利多卡因的克雷布斯-亨塞尔特缓冲液(10毫摩尔/升葡萄糖,37℃时pH 7.6 - 7.7)或含500微摩尔利多卡因的克雷布斯-亨塞尔特缓冲液在60毫米汞柱压力下停搏40或60分钟。
腺苷-利多卡因组的停搏时间为7至10秒,利多卡因组为102秒(P <.05)。对于40分钟和60分钟的腺苷-利多卡因停搏方案,间断(每18分钟2分钟)和持续输注的总心脏停搏液量分别为122至159毫升和699至922毫升,60分钟间断利多卡因组为136毫升。在40分钟和60分钟停搏方案的最后2分钟,用腺苷和利多卡因停搏的心脏的冠状动脉血管阻力无显著差异(0.27 - 0.3